Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis

ClinicalTrials.gov ID: NCT02696798

Public ClinicalTrials.gov record NCT02696798. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 3:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the efficacy and safety of ixekizumab in tumor necrosis factor (TNF) inhibitor-experienced participants with radiographic axial spondyloarthritis (rad-axSpA).

Study identification

NCT ID
NCT02696798
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
316 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 12, 2016 (Actual)
Primary completion
May 18, 2018 (Actual)
Completion
May 3, 2019 (Actual)
Last update posted
Jun 17, 2020

2016 – 2019

United States locations

U.S. sites
27
U.S. states
19
U.S. cities
27
Facility City State ZIP Site status
Arizona Arthritis Research, PLC Phoenix Arizona 85032 —
Rheumatology Center of San Diego Escondido California 92025 —
Care Access Research - Huntington Beach Huntington Beach California 92648 —
Desert Medical Advances Palm Desert California 92260 —
Arthritis Assoc. & Osteoporosis Ctr of Colorado Springs, LLC Colorado Springs Colorado 80920 —
Denver Arthritis Center Denver Colorado 80230 —
Clinical Research Center of CT/NY Danbury Connecticut 06810 —
Arthritis Rheumatic Disease Specialties Aventura Florida 33180 —
Sarasota Arthritis Center Sarasota Florida 34239 —
Marietta Rheumatology Marietta Georgia 30060 —
St Luke's Clinic - Intermountain Orthopaedics Boise Idaho 83702 —
Institute of Arthritis Research Idaho Falls Idaho 83404 —
Center for Arthritis & Osteoporosis Elizabethtown Kentucky 42701 —
Klein and Associates MD, PA Cumberland Maryland 21502 —
Osteoporosis And Clinical Trial Center Hagerstown Maryland 21740 —
Arthritis Consultants St Louis Missouri 63141 —
The Center for Rheumatology Albany New York 12203 —
Shanahan Rheumatology & Immunotherapy Raleigh North Carolina 27617 —
Oregon Health and Science University Portland Oregon 97239 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
Articularis Healthcare Group, INC dba Columbia Arthritis Ctr Columbia South Carolina 29204 —
Low Country Research Center North Charleston South Carolina 29406 —
Univ of Texas Health Science Center - Houston Houston Texas 77030 —
Southwest Rheumatology, P.A. Mesquite Texas 75150 —
Center for Arthritis and Rheumatic Diseases, PC Chesapeake Virginia 23320 —
Arthritis Northwest Rheumatology Spokane Washington 99204 —
Rheumatology and Immunotherapy Center Franklin Wisconsin 53132 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 72 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02696798, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 17, 2020 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02696798 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →